AbCellera secures COVID-19 drug development funding

By The Science Advisory Board staff writers

May 4, 2020 -- AbCellera Biologics has secured $175.6 million Canadian ($124.7 million U.S.) from the Canadian government's Innovation, Science, and Economic Development Strategic Innovation Fund to advance its efforts to discover antibodies for use in antiviral COVID-19 drugs.

The company developed an antibody discovery platform to search blood samples of people who have recovered from COVID-19. In a collaboration with the U.S. National Institutes of Health, it has identified more than 500 anti-SARS-CoV-2 antibodies since February 25.

Under phase I of the Canadian collaboration, AbCellera will improve its antibody discovery platform for finding COVID-19 antibodies, while under phase II, it will build a new good manufacturing practice (GMP) facility in Vancouver to produce antibodies from patient samples for clinical trials.

AbCellera recently announced a partnership with Eli Lilly to develop a COVID-19 treatment, with clinical trials beginning in July, it said.

Copyright © 2020

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.